Effect of o,p′-DDD and Li+ on apoptotic DNA fragmentation in conventionally normal and tumour tissues of human adrenal cortex

Ukrain'skyi Biokhimichnyi Zhurnal

Volumn 79, Issue 2, 2007, Pages 44-49

  Pushkarev, V M ^a   Tronko, N D ^a   Kostyuchenko, N N ^a   Mikosha, A S ^a  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

Author keywords

Apoptosis; Human adrenal tumours; K+; Li+; o,p DDD

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; LITHIUM CHLORIDE; MITOTANE; POTASSIUM CHLORIDE;

ADRENAL CORTEX; ADRENAL CORTEX TUMOR; APOPTOSIS; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; DNA FRAGMENTATION; DRUG EFFECT; HUMAN; PATHOLOGY;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; DNA FRAGMENTATION; HUMANS; LITHIUM CHLORIDE; MITOTANE; POTASSIUM CHLORIDE; TUMOR CELLS, CULTURED;

EID: 34548230567     PISSN: 02018470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hammond L. J., Lowdell M. W., Cerrano P. G. et al. // J. Pathol. - 1997. - 182. - P. 138-144.
2. Kolesnick R. N., Krönke M. // Ann. Rev. Physiol. - 1998. - 60. - P. 643-665.
3. Kroemer G. // Oncogene. - 2004. - 23. - P. 2744-2745.
4. Kerr J. F. R., Winterford C. M., Harmon B. V. // Cancer. - 1994. - 73. - P. 2013-2026.
5. Mikosha A. S., Kostyuchenko N. N., Pushkarev V. M. // Exp. Oncol. - 1999. - 21, N 1. - P. 64-69.
6. Diezi J., Biollaz J. // Lithium and the endocrine system / Ed. F. N. Johnson. Basel, Karger. - 1988. - P. 159-167.
7. Balla P., Enyedi P., Hunyady L., Spat A. // FEBS Lett. - 1984. - 171. - P. 179-182.
8. Chen G., Masana M. I., Manji H. K. // Bipolar Disord. - 2000. - 2. - P. 217-236.
9. Phiel C. J., Klein P. S. // Ann. Rev. Pharmacol. Toxicol. - 2001. - 41. - P. 789-813.
10. Pushkarev V. M., Mikosha A. S. // Biomed. Sci. - 1991. - 2, N 2. - P. 135-139.
11. Kostyuchenko N., Pushkarev V., Kashevarov G. et al. // Exp. Oncol. - 2005. - 27, N 3. - P. 215-219.
12. Rowe M. K., Chuan D. M. // Expert Rev. Mol. Med. - 2004. - 6. - P. 1-18.
13. Hongisto V., Smeds N. Brecht S. et al. // Mol. Cell. Biol. - 2003. - 23, N 17. - P. 6027-6036.
14. Kang H. J., Noh J. S., Bae Y. S., Gwag B. J. // Mol. Pharmacol. - 2003. - 64, N 2. - P. 228-234.
15. Nemeth Z. H., Deitch E. A., Szabo C. et al. // J. Biol. Chem. - 2002. - 277, N 10. - P. 7713-7719.
16. Polakis P. // Gen. Devel. - 2000. - 14. - P. 1837-1851.
17. Kucharczak J., Simmons M. J., Fan I., Gelinas C. // Oncogene. - 2003. - 22. - P. 8961-8982.
18. Liao X., Zhang L., Phrasher J. B. et al. // Mol. Cancer Ther. - 2003. - 2, N 11. - P. 1215-1222.
19. Shai L. J., Abotsi E. K., Pyobekai E. M., Wachira J. M. // Cell. Mol. Biol. - 2003. - 49, N7. - P. 1137-1143.
20. Song L., Zhou P., Jope R. S. // BMC Neurosci. - 2004. - 5, N 1. - P. 20.
21. Gibbs J. B. // J. Clin. Invest. - 2000. - 105, N 1. - P. 9-13.